These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model. Russo G; Stefano A; Alongi P; Comelli A; Catalfamo B; Mantarro C; Longo C; Altieri R; Certo F; Cosentino S; Sabini MG; Richiusa S; Barbagallo GMV; Ippolito M Curr Oncol; 2021 Dec; 28(6):5318-5331. PubMed ID: 34940083 [TBL] [Abstract][Full Text] [Related]
3. Radiomics: a novel feature extraction method for brain neuron degeneration disease using Li Y; Jiang J; Lu J; Jiang J; Zhang H; Zuo C Ther Adv Neurol Disord; 2019; 12():1756286419838682. PubMed ID: 30956687 [TBL] [Abstract][Full Text] [Related]
4. Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on Zhou P; Zeng R; Yu L; Feng Y; Chen C; Li F; Liu Y; Huang Y; Huang Z; Front Aging Neurosci; 2021; 13():764872. PubMed ID: 34764864 [No Abstract] [Full Text] [Related]
5. Predicting amyloid positivity from FDG-PET images using radiomics: A parsimonious model. Rasi R; Guvenis A; Comput Methods Programs Biomed; 2024 Apr; 247():108098. PubMed ID: 38442621 [TBL] [Abstract][Full Text] [Related]
6. Coupled Imaging with [ Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839 [TBL] [Abstract][Full Text] [Related]
7. Use of amyloid PET/CT with Ferrari C; Caputo P; Pisani AR; Nappi AG; Branca A; Lavelli V; Rubini G Hell J Nucl Med; 2019; 22 Suppl 2():142-152. PubMed ID: 31802055 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow segmentation and radiomics analysis of [ Milara E; Gómez-Grande A; Tomás-Soler S; Seiffert AP; Alonso R; Gómez EJ; Martínez-López J; Sánchez-González P Comput Methods Programs Biomed; 2022 Oct; 225():107083. PubMed ID: 36044803 [TBL] [Abstract][Full Text] [Related]
9. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535 [TBL] [Abstract][Full Text] [Related]
10. Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253 [No Abstract] [Full Text] [Related]
11. Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study. Tripathi M; Tripathi M; Sharma R; Jaimini A; Md'souza M; Saw S; Mondal A; Kushwaha S Indian J Nucl Med; 2013 Jul; 28(3):129-33. PubMed ID: 24250019 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of early-phase [ Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429 [TBL] [Abstract][Full Text] [Related]
13. Framework for Machine Learning of CT and PET Radiomics to Predict Local Failure after Radiotherapy in Locally Advanced Head and Neck Cancers. Devakumar D; Sunny G; Sasidharan BK; Bowen SR; Nadaraj A; Jeyseelan L; Mathew M; Irodi A; Isiah R; Pavamani S; John S; T Thomas HM J Med Phys; 2021; 46(3):181-188. PubMed ID: 34703102 [TBL] [Abstract][Full Text] [Related]
14. Machine Learning Model to Predict Diagnosis of Mild Cognitive Impairment by Using Radiomic and Amyloid Brain PET. Ciarmiello A; Giovannini E; Pastorino S; Ferrando O; Foppiano F; Mannironi A; Tartaglione A; Giovacchini G; Clin Nucl Med; 2023 Jan; 48(1):1-7. PubMed ID: 36240660 [TBL] [Abstract][Full Text] [Related]
15. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI. Tripathi M; Tripathi M; Parida GK; Kumar R; Dwivedi S; Nehra A; Bal C Neurol India; 2019; 67(5):1310-1317. PubMed ID: 31744965 [TBL] [Abstract][Full Text] [Related]
16. Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [ Chiaravalloti A; Barbagallo G; Martorana A; Castellano AE; Ursini F; Schillaci O Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1796-1805. PubMed ID: 31201430 [TBL] [Abstract][Full Text] [Related]
17. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma. Yousefirizi F; Gowdy C; Klyuzhin IS; Sabouri M; Tonseth P; Hayden AR; Wilson D; Sehn LH; Scott DW; Steidl C; Savage KJ; Uribe CF; Rahmim A Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539425 [TBL] [Abstract][Full Text] [Related]
18. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients. Alongi P; Stefano A; Comelli A; Laudicella R; Scalisi S; Arnone G; Barone S; Spada M; Purpura P; Bartolotta TV; Midiri M; Lagalla R; Russo G Eur Radiol; 2021 Jul; 31(7):4595-4605. PubMed ID: 33443602 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using Chen Z; Bi S; Shan Y; Cui B; Yang H; Qi Z; Zhao Z; Han Y; Yan S; Lu J CNS Neurosci Ther; 2024 Apr; 30(4):e14539. PubMed ID: 38031997 [TBL] [Abstract][Full Text] [Related]
20. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study. Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]